MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway

Cell Proliferation

Volumn 47, Issue 2, 2014, Pages 152-160

  Li, J ^a   You, T ^a   Jing, J ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 125B; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE 3 KINASE CATALYTIC SUBUNIT DELTA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOINFORMATICS; CARCINOGENESIS; CELL CYCLE PHASE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLOGY; DOWN REGULATION; ENZYME PHOSPHORYLATION; EWING SARCOMA; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MIGRATION; ONCOGENE; PREDICTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BONE NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA, NEOPLASM; SARCOMA, EWING; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84895922568     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12093     Document Type: Article

References (23)

1. Iwamoto Y (2007) Diagnosis and treatment of Ewing's sarcoma. Jpn. J. Clin. Oncol. 37, 79-89.
2. Borinstein SC, Beeler N, Block JJ, Gorlick R, Grohar P, Jedlicka P et al. (2013) A decade in banking Ewing sarcoma: a report from the Children's Oncology Group. Front. Oncol. 3, 57.
3. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M (2012) microRNAs in cancer management. Lancet Oncol. 13, e249-e258.
5. Olsen PH, Ambros V (1999) The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol. 216, 671-680.
6. De Vito C, Riggi N, Suva ML, Janiszewska M, Horlbeck J, Baumer K et al. (2011) Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development. PLoS One 6, e23592.
7. McKinsey EL, Parrish JK, Irwin AE, Niemeyer BF, Kern HB, Birks DK et al. (2011) A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs. Oncogene 30, 4910-4920.
8. Li Z, Gu X, Fang Y, Xiang J, Chen Z (2012) microRNA expression profiles in human colorectal cancers with brain metastases. Oncol. Lett. 3, 346-350.
9. Tang F, Zhang R, He Y, Zou M, Guo L, Xi T (2012) microRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. PLoS One 7, e35435.
10. Glud M, Rossing M, Hother C, Holst L, Hastrup N, Nielsen FC et al. (2010) Downregulation of miR-125b in metastatic cutaneous malignant melanoma. Melanoma Res. 20, 479-484.
11. Machado I, Lopez-Guerrero JA, Navarro S, Alberghini M, Scotlandi K, Picci P et al. (2012) Epithelial cell adhesion molecules and epithelial mesenchymal transition (EMT) markers in Ewing's sarcoma family of tumors (ESFTs). Do they offer any prognostic significance? Virchows Arch. 461, 333-337.
12. Cui F, Li X, Zhu X, Huang L, Huang Y, Mao C et al. (2012) MiR-125b inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting phosphoinositide 3-kinase catalytic subunit delta. Cell. Physiol. Biochem. 30, 1310-1318.
13. Leonardo TR, Schultheisz HL, Loring JF, Laurent LC. The functions of microRNAs in for review only pluripotency and reprogramming. Nat. Cell Biol. 14, 1114-1121.
14. Ban J, Jug G, Mestdagh P, Schwentner R, Kauer M, Aryee DN et al. (2011) Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma. Oncogene 30, 2173-2180.
15. Franzetti GA, Laud-Duval K, Bellanger D, Stern MH, Sastre-Garau X, Delattre O (2012) MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor. Oncogene 32, 3915-3921.
16. Anna ME, Jason GH, Paolo N, Christopher G, Joshua JO, Riccardo S et al. (2010) MiR-328 functions as an RNA decoy to modulate hnRNP E2 Regulation of mRNA translation in leukemic blasts. Cell 140, 652-665.
17. Martin-Sanchez E, Rodriguez-Pinilla SM, Sanchez-Beato M, Lombardia L, Dominguez-Gonzalez B, Romero D et al. (2013) Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas. Haematologica 98, 57-64.
18. Hotfilder M, Sondermann P, Senss A, van Valen F, Jurgens H, Vormoor J (2005) PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death. Br. J. Cancer 92, 705-710.
19. Yamamoto T, Ohno T, Wakahara K, Nagano A, Kawai G, Saitou M et al. (2009) Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma. J. Cancer Res. Clin. Oncol. 135, 1125-1136.
20. Toretsky JA, Thakar M, Eskenazi AE, Frantz CN (1999) Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors. Cancer Res. 59, 5745-5750.
21. Sheppard K, Kinross KM, Solomon B, Pearson RB, Phillips WA (2012) Targeting PI3 kinase/AKT/mTOR signaling in cancer. Crit. Rev. Oncog. 17, 69-95.
22. Gong J, Zhang JP, Li B, Zeng C, You K, Chen MX et al. (2013) MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w, and IL-6R. Oncogene 32, 3071-3079.
23. Chou CH, Lai SL, Chen CN, Lee PH, Peng FC, Kuo ML et al. (2013) IL-6 regulates Mcl-1L expression through the JAK/PI3K/AKT/CREB signaling pathway in hepatocytes: implication of an anti-apoptotic role during liver regeneration. PLoS One 8, e66268.